Combining anti-VEGF agents with corticosteroids (e.g., Ozurdex) may offer a synergistic effect, where the anti-VEGF component reduces vascular permeability and the steroid addresses inflammation and macular edema [60,61]. The gene discussed is VEGFA; the disease is macular retinal edema.